Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 705

1.

Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).

Daemen J, Tanimoto S, García-García HM, Kukreja N, van de Sande M, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW.

Am J Cardiol. 2007 Apr 15;99(8):1027-32. Epub 2007 Mar 6.

PMID:
17437722
3.

Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.

Lee CW, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Yun SC, Seong IW, Lee JH, Lee NH, Cho YH, Cheong SS, Lim DS, Yang JY, Lee SG, Kim KS, Yoon J, Jeong MH, Seung KB, Hong TJ, Park SJ; ZEST-AMI Investigators.

Am J Cardiol. 2009 Nov 15;104(10):1370-6. doi: 10.1016/j.amjcard.2009.06.059. Epub 2009 Sep 26.

PMID:
19892052
4.
5.

Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.

Kim YH, Park SW, Lee CW, Hong MK, Gwon HC, Jang Y, Lee MM, Koo BK, Oh DJ, Seung KB, Tahk SJ, Yoon J, Park SJ.

Catheter Cardiovasc Interv. 2006 Feb;67(2):181-7.

PMID:
16400663
6.

Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.

Simsek C, Onuma Y, Magro M, de Boer S, Battes L, van Domburg RT, Boersma E, Serruys PW; Interventional Cardiologists of the Thoraxcenter (2000-2005).

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):41-9. doi: 10.1002/ccd.22533.

PMID:
20310019
7.

Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction.

Newell MC, Henry CR, Sigakis CJ, Unger BT, Larson DM, Chavez IJ, Burke MN, Traverse JH, Henry TD.

Am J Cardiol. 2006 May 1;97(9):1299-302. Epub 2006 Mar 10.

PMID:
16635599
8.

Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.

Barlis P, Kaplan S, Dimopoulos K, Ferrante G, Di Mario C.

Cardiology. 2008;111(4):270-6. doi: 10.1159/000128602. Epub 2008 May 2.

PMID:
18451644
9.

Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.

Kim BK, Oh S, Jeon DW, Yang JY, Kim JS, Park S, Choi D, Jang Y, Hong BK, Kwon HM, Lee SW, Goh CW, Kwon K, Ryu SK; Korean Multicenter Angioplasty Team (KOMATE) Investigators.

J Interv Cardiol. 2009 Oct;22(5):411-9. doi: 10.1111/j.1540-8183.2009.00495.x. Epub 2009 Aug 20.

PMID:
19702679
10.

Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries).

Cheng JM, Onuma Y, Piazza N, Nuis RJ, Van Domburg RT, Serruys PW; Interventional Cardiologists of Thoraxcenter (2000-2009).

Am J Cardiol. 2010 Nov 15;106(10):1376-81. doi: 10.1016/j.amjcard.2010.07.007. Epub 2010 Oct 1.

PMID:
21059424
12.
13.

Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).

Weisz G, Moses JW, Teirstein PS, Holmes DR Jr, Raizner AE, Satler LF, Mishkel G, Wilensky RL, Wang P, Kuntz RE, Popma JJ, Leon MB.

Am J Cardiol. 2007 Apr 15;99(8):1044-50. Epub 2007 Feb 26.

PMID:
17437725
14.

Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.

Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A.

Circulation. 2007 Jun 26;115(25):3181-8. Epub 2007 Jun 11.

15.

5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R.

J Am Coll Cardiol. 2009 Sep 1;54(10):894-902. doi: 10.1016/j.jacc.2009.04.077.

16.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Review.

PMID:
19360858
17.

Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.

Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Alfonso F, Hernández-Antolín R, SanMartín M, Gómez-Hospital JA, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C; DIABETES Investigators.

Eur Heart J. 2007 Aug;28(16):1946-52. Epub 2007 Jun 11.

PMID:
17562666
18.

One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents.

Hofma SH, Ong AT, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Valgimigli M, Regar E, de Jaegere PP, McFadden EP, Sianos G, van der Giessen WJ, de Feyter PJ, Van Domburg RT, Serruys PW.

Heart. 2005 Sep;91(9):1176-80. Epub 2005 May 9.

19.

Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.

Slottow TL, Steinberg DH, Roy P, Javaid A, Buch AN, Okabe T, Xue Z, Smith K, Torguson R, Pichard AD, Satler LF, Suddath WO, Kent KM, Waksman R.

Cardiovasc Revasc Med. 2008 Jan-Mar;9(1):24-8. doi: 10.1016/j.carrev.2007.06.002.

PMID:
18206634
20.

Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).

Hamirani YS, Jibrin I, Abraham D, Merriman B, Wenz C, Bahr RD.

Crit Pathw Cardiol. 2008 Dec;7(4):232-8. doi: 10.1097/HPC.0b013e3181805e0b.

PMID:
19050419

Supplemental Content

Support Center